Società Merck & Co., Inc.

MRK

US58933Y1055

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per Merck & Co., Inc.

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 26/04/2024			Variaz. 5gg	Var. 1 gen.
131,2 ^USD	+0,37%		+4,31%	+20,34%

26/04	MERCK & CO., INC. : Wolfe Research Neutral sul caso	ZM
26/04	MERCK & CO., INC. : Morgan Stanley conferma il rating Buy	ZM

Merck & Co. Inc. è specializzata nello sviluppo, nella produzione e nella commercializzazione di prodotti terapeutici e vaccini venduti dietro prescrizione medica. Le vendite nette sono così suddivise per attività:
- vendita di prodotti farmaceutici (69,7%): per il trattamento di ipertensione, osteoporosi, aterosclerosi, malattie respiratorie, batteriche e fungine, oftalmologiche e urologiche, emicrania acuta, perdita di capelli negli uomini, ecc;
- vendita di vaccini (18%);
- vendita di prodotti per la salute degli animali (9,4%);
- altro (2,9%).
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (45,9%), Europa/Medio Oriente/Africa (24,5%), Cina (8,8%), Giappone (6,1%), Asia/Pacifico (6,1%), America Latina (4,3%) e altro (4,3%).

Numero di dipendenti: 71 000

USD in Milioni	2022	Peso	2023	Peso	Delta
Pharmaceutical 89,1 %	52 005	87,7 %	53 583	89,1 %	+3,03%
Animal Health 9,4 %	5 550	9,4 %	5 625	9,4 %	+1,35%
Other 1,5 %	1 728	2,9 %	907	1,5 %	-47,51%

USD in Milioni	2022	Peso	2023	Peso	Delta
United States 47,4 %	27 206	45,9 %	28 480	47,4 %	+4,68%
Europe, Middle East and Africa 22,0 %	14 493	24,4 %	13 254	22,0 %	-8,55%
China 11,3 %	5 191	8,8 %	6 802	11,3 %	+31,03%
Asia Pacific 5,4 %	3 614	6,1 %	3 225	5,4 %	-10,76%
Japan 5,3 %	3 629	6,1 %	3 164	5,3 %	-12,81%
Latin America 5,1 %	2 582	4,4 %	3 086	5,1 %	+19,52%
Other 3,5 %	2 568	4,3 %	2 104	3,5 %	-18,07%

Dirigenti	Titolo	Età	Da
Robert Davis CEO	Chief Executive Officer	57	01/04/14
Caroline Litchfield DFI	Director of Finance/CFO	55	01/01/90
Dave Williams CTO	Chief Tech/Sci/R&D Officer	55	01/08/20
Joseph Romanelli IRC	Investor Relations Contact	50	01/01/96
Peter Dannenbaum IRC	Investor Relations Contact	-	01/07/17
Andre Musto PRN	Corporate Officer/Principal	-	01/07/14
Brooke Hinkson PRN	Corporate Officer/Principal	-	01/08/15
Carol Bowden PRN	Corporate Officer/Principal	-	01/04/14
Dalton Smart AUD	Comptroller/Controller/Auditor	58	01/11/09
James Matteucci PRN	Corporate Officer/Principal	-	01/01/03

Amministratori	Titolo	Età	Da
Tom Glocer BRD	Director/Board Member	63	27/11/07
Pamela Craig BRD	Director/Board Member	67	01/09/15
Inge Thulin BRD	Director/Board Member	69	01/03/18
Patricia Russo BRD	Director/Board Member	71	01/09/95
Peter Wendell BRD	Director/Board Member	73	23/09/03
Risa Lavizzo-Mourey BRD	Director/Board Member	69	26/05/20
Robert Davis CEO	Chief Executive Officer	57	01/04/14
Douglas Baker BRD	Director/Board Member	65	24/05/22
Stephen Mayo BRD	Director/Board Member	62	15/03/21
Kathy Warden BRD	Director/Board Member	52	16/03/20

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	3 578 498 438	2 531 740 409 ( 70,75 %)	1 045 470 249 ( 29,22 %)	70,75 %

Nome	Azioni	%	Valorizzazione
Vanguard Fiduciary Trust Co. 9,665 %	244 776 747	9,665 %	32 298 M $
BlackRock Advisors LLC 6,098 %	154 441 634	6,098 %	20 379 M $
STATE STREET CORPORATION 4,614 %	116 865 977	4,614 %	15 420 M $
Wellington Management Co. LLP 3,380 %	85 595 999	3,380 %	11 294 M $
Geode Capital Management LLC 2,189 %	55 428 245	2,189 %	7 314 M $
Fidelity Management & Research Co. LLC 1,688 %	42 749 954	1,688 %	5 641 M $
Merrill Lynch International 1,591 %	40 288 789	1,591 %	5 316 M $
BlackRock Life Ltd. 1,590 %	40 271 751	1,590 %	5 314 M $
Eaton Vance Management 1,585 %	40 129 825	1,585 %	5 295 M $
Charles Schwab Investment Management, Inc. 1,448 %	36 682 866	1,448 %	4 840 M $

Nome	Azioni	%	Valorizzazione
Caixa DTVM SA 0,001468 %	297 420	0,001468 %	5 M $
BB Gestão de Recursos DTVM SA 0,000733 %	148 500	0,000733 %	2 M $
Safra Asset Management Ltda. 0,000363 %	73 600	0,000363 %	1 M $
Bram Bradesco Asset Management S/A DTVM 0,000231 %	46 754	0,000231 %	771 893 $
XP Allocation Asset Management Ltda. 0,000093 %	18 843	0,000093 %	311 092 $

Nome	Azioni	%	Valorizzazione
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. 10.62%	13 443 693	10.62%	266 247 500 $
ENTRADA THERAPEUTICS, INC. 5.18%	1 739 768	5.18%	24 652 513 $
XILIO THERAPEUTICS, INC. 5.39%	1 483 414	5.39%	1 602 087 $
EVAXION BIOTECH A/S 12.13%	2 297 884	12.13%	735 323 $

Merck & Co., Inc.

126 East Lincoln Avenue

07065, Rahway

+908 740 4000

http://www.merck.com

Nome	Categoria e settore
FULFORD (INDIA) LIMITED	Pharmaceuticals: Major
Organon (India) Pvt Ltd. Organon (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Organon India Pvt Ltd. manufactures and distribution of pharmaceutical preparations. The company is headquartered in Mumbai, India.	Pharmaceuticals: Major
Dashtag Dashtag Financial ConglomeratesFinance Founded in 1906, Dashtag is a part of Organon & Co. and operates an investment holding British company. The private company is based in Hoddesdon, UK.	Financial Conglomerates
MSD Sharp & Dohme GmbH MSD Sharp & Dohme GmbH Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Sharp & Dohme GmbH develops and manufactures pharmaceutical products. The private company is based in Haar, Germany. The German company was founded in 1891. Chantal Friebertshäuser has been the CEO of the company since 2007.	Pharmaceuticals: Major
Merck Holdings, Inc.
Merck Sharp & Dohme Corp. Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.	Pharmaceuticals: Major
Intervet India Pvt Ltd.
Essex Chemie AG
Merck Sharp & Dohme Finance Europe Ltd. Merck Sharp & Dohme Finance Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1993, Merck Sharp & Dohme Finance Europe Ltd. is a British company that provides business support services. Part of Merck & Co., Inc., the private company is based in Hoddesdon, UK.	Miscellaneous Commercial Services
Schering Plough International Finance Co. BV
Merck Sharp & Dohme BV Merck Sharp & Dohme BV Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme BV is a Dutch company that manufactures and distributes pharmaceutical products. The private company is based in Haarlem, the Netherlands.	Pharmaceuticals: Major
MSD Pharmaceuticals Pvt Ltd.
MSD Finance 2 LLC
MSD Animal Health Pension Scheme MSD Animal Health Pension Scheme Investment ManagersFinance Part of Merck & Co., Inc., MSD Animal Health Pension Scheme is a British company. The private company is located in the UK.	Investment Managers
Merck International Holdings LLC
MSD Human Health Holding BV MSD Human Health Holding BV Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Human Health Holding BV discovers, develops and markets human and animal health products. The private company is based in Oss, Netherlands.	Pharmaceuticals: Major
MSD FI BV MSD FI BV Financial ConglomeratesFinance Part of Merck & Co., Inc., MSD FI BV is an investment holding Dutch company. The private company is based in Haarlem, Netherlands.	Financial Conglomerates
MSD International GmbH (Switzerland) MSD International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD International GmbH (Switzerland) is a Swiss company that discovers, develops and markets human and animal health products. The private company is located in Switzerland.	Pharmaceuticals: Major
Merck Sharp & Dohme Manufacturing Unlimited Co.
MSD Pharmaceuticals Investments 3 (Bermuda) MSD Pharmaceuticals Investments 3 (Bermuda) Financial ConglomeratesFinance Part of Merck & Co., Inc., MSD Pharmaceuticals Investments 3 (Bermuda) provides investment services. The private company is located in Bermuda.	Financial Conglomerates
MSD International Business GmbH
GTS FI BV GTS FI BV Financial ConglomeratesFinance Part of Organon & Co., GTS FI BV is an investment holding Dutch company that provides financing services. The private company is located in Netherlands.	Financial Conglomerates
Merck Sharp & Dohme LLC Merck Sharp & Dohme LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme LLC is a pharmaceutical company. The private company is based in Kenilworth, NJ.	Pharmaceuticals: Major
Organon LLC
MSD Regional Business Support Center GmbH MSD Regional Business Support Center GmbH Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., MSD Regional Business Support Center GmbH is a German company that provides management consulting services. The private company is based in Munich, Germany. Jutta König has been the CEO of the company since 2021.	Miscellaneous Commercial Services

Rating Trading

Rating Investimento

ESG Refinitiv

B-

Altri rating

Vendita

Buy

Raccomandazione media

Buy

Numero di analisti

Ultimo prezzo di chiusura

131,2 USD

Prezzo obiettivo medio

140,7 USD

Differenza / Target Medio

+7,27%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
MERCK & CO., INC.	+20,34%	332 Mrd
ELI LILLY AND COMPANY	+25,83%	661 Mrd
NOVO NORDISK A/S	+27,00%	566 Mrd
JOHNSON & JOHNSON	-6,76%	352 Mrd
ABBVIE INC.	+3,00%	283 Mrd
ASTRAZENECA PLC	+13,09%	231 Mrd
NOVARTIS AG	+5,46%	200 Mrd
ROCHE HOLDING AG	-9,61%	195 Mrd
AMGEN INC.	-6,26%	145 Mrd
PFIZER, INC.	-11,77%	144 Mrd

Prodotti farmaceutici - Altri